Strategies to manage hepatitis C virus infection disease burden – volume 3

LAUR Repository

Show simple item record

dc.contributor.author Mokhbat, J. E.
dc.contributor.author Alfaleh, F. Z.
dc.contributor.author Nugrahini, N.
dc.contributor.author Maticic, M.
dc.contributor.author Tolmane, I.
dc.contributor.author Alzaabi, M.
dc.contributor.author Hajarizadeh, B.
dc.contributor.author Valantinas, J.
dc.date.accessioned 2017-02-10T14:12:27Z
dc.date.available 2017-02-10T14:12:27Z
dc.date.copyright 2015 en_US
dc.date.issued 2017-02-10
dc.identifier.issn 1352-0504 en_US
dc.identifier.uri http://hdl.handle.net/10725/5213
dc.description.abstract The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 15 countries in Europe, the Middle East and Asia, and the relative impact of two scenarios was considered: [1] increased treatment efficacy while holding the annual number of treated patients constant and [2] increased treatment efficacy and an increased annual number of treated patients. Increasing levels of diagnosis and treatment, in combination with improved treatment efficacy, were critical for achieving substantial reductions in disease burden. A 90% reduction in total HCV infections within 15 years is feasible in most countries studied, but it required a coordinated effort to introduce harm reduction programmes to reduce new infections, screening to identify those already infected and treatment with high cure rate therapies. This suggests that increased capacity for screening and treatment will be critical in many countries. Birth cohort screening is a helpful tool for maximizing resources. Among European countries, the majority of patients were born between 1940 and 1985. A wider range of birth cohorts was seen in the Middle East and Asia (between 1925 and 1995). en_US
dc.language.iso en en_US
dc.title Strategies to manage hepatitis C virus infection disease burden – volume 3 en_US
dc.type Article en_US
dc.description.version Published en_US
dc.author.school SOM en_US
dc.author.idnumber 200902719 en_US
dc.author.department N/A en_US
dc.description.embargo N/A en_US
dc.relation.journal Journal of Viral Hepatitis en_US
dc.journal.volume 22 en_US
dc.journal.issue S4 en_US
dc.article.pages 42-65 en_US
dc.identifier.doi http://dx.doi.org/10.1111/jvh.12474 en_US
dc.identifier.ctation Alfaleh, F. Z., Nugrahini, N., Matičič, M., Tolmane, I., Alzaabi, M., Hajarizadeh, B., ... & Abbas, Z. (2015). Strategies to manage hepatitis C virus infection disease burden–volume 3. Journal of viral hepatitis, 22(S4), 42-65. en_US
dc.author.email jacques.mokhbat@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url http://onlinelibrary.wiley.com/doi/10.1111/jvh.12474/full en_US
dc.author.affiliation Lebanese American University en_US

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search LAUR

Advanced Search


My Account